IPO
Cabaletta Bio
Biotechnology
We are a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases.
Symbol
CABA
Price Range
$14.00 - $16.00
Anticipated Date
October 25, 2019
Underwriters
MORGAN STANLEY & CO. LLC,COWEN AND COMPANY, LLC
This offering is no longer available
Sign Up to participate in future offerings
To view the prospectus for Cabaletta Bio IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277